Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma

3Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative approach in treating advanced hepatocellular carcinoma (HCC). Despite their success, challenges persist, including concerns about their effectiveness, treatment costs, frequent occurrence of treatment-related adverse events, and tumor hyperprogression. Therefore, it is imperative to identify indicators capable of predicting the efficacy of ICIs treatment, enabling optimal patient selection to maximize clinical benefits while minimizing unnecessary toxic side effects and economic losses. This review paper categorizes prognostic biomarkers of ICIs treatment into the following categories: biochemical and cytological indicators, tumor-related markers, imaging and personal features, etiology, gut microbiome, and immune-related adverse events (irAEs). By organizing these indicators systematically, we aim to guide biomarker exploration and inform clinical treatment decisions.

References Powered by Scopus

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

75829Citations
N/AReaders
Get full text

Sorafenib in advanced hepatocellular carcinoma

10639Citations
N/AReaders
Get full text

Signatures of mutational processes in human cancer

7487Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Advancements in the Treatment Landscape of Hepatocellular Carcinoma

0Citations
N/AReaders
Get full text

Five-Year Sustained Response to Nivolumab in Hepatocellular Carcinoma following Serious Immune-Related Hepatitis

0Citations
N/AReaders
Get full text

Efficacy and safety of nivolumab plus ipilimumab in gastrointestinal cancers: a systematic review and meta-analysis

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Qin, R., Jin, T., & Xu, F. (2023). Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma. Frontiers in Immunology. Frontiers Media SA. https://doi.org/10.3389/fimmu.2023.1326097

Readers' Seniority

Tooltip

Researcher 2

50%

Lecturer / Post doc 1

25%

PhD / Post grad / Masters / Doc 1

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

57%

Biochemistry, Genetics and Molecular Bi... 1

14%

Nursing and Health Professions 1

14%

Computer Science 1

14%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 4

Save time finding and organizing research with Mendeley

Sign up for free